Seconeolitsine is an antibiotic that inhibits topoisomerase I (TopA) and exhibits antibacterial activity against Streptococcus pneumoniae, including strains resistant to other antibiotics; it can be used in the study of S. pneumoniae infections resistant to conventional antibiotics.